Cargando…
Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease
Pioglitazone is currently undergoing clinical trials for treatment of Alzheimer's disease (AD). However, poor brain penetration remains an obstacle to development of the drug for such intended clinical uses. In this study, we demonstrate that the inhibition of P-glycoprotein (P-gp) significantl...
Autores principales: | Chang, Kai Lun, Pee, Hai Ning, Yang, Shili, Ho, Paul C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390903/ https://www.ncbi.nlm.nih.gov/pubmed/25760794 http://dx.doi.org/10.1038/srep09000 |
Ejemplares similares
-
Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021) -
Influence of trazodone on the pharmacodynamics and pharmacokinetics of pioglitazone
por: Pradeepkumar, Bhupalam, et al.
Publicado: (2022) -
Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease
por: Fernandez-Martos, Carmen M., et al.
Publicado: (2016) -
Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats
por: Biswas, Arghya, et al.
Publicado: (2012) -
Protecting Groups in Carbohydrate Chemistry: Influence on Stereoselectivity of Glycosylations
por: Guo, Jian, et al.
Publicado: (2010)